Biolargo, Inc.
BLGO· OTC
BLGOBiolargo, Inc.
Filed Aug 14, 2026 · 10-Q · 45 days after period end · 0001437749-26-028023
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.25M | $2.78M | $5.01M | $1.45M |
| Net Income | -$4.00M | -$1.88M | -$780.00K | -$1.63M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end
